USSTOCK.TODAY
Market Closed
Log in Sign up

Ensysce Bioscience Announces Acquisition of Sci Biopharma and Third Quarter Results

ACCESSWIRE +1 · ·by G4L

ENSC
ENSC Ensysce Biosciences Inc
$0.42 +8.06%
View chart & analysis →
  1. 1Ensysce Bioscience completed the acquisition of Sci Biopharma in August 2026.
  2. 2Ensysce recorded $29.7 million in cash and cash equivalents for the third quarter ended September 30, 2026.
  3. 3The UK Medicines and Healthcare products Regulatory Agency requested additional information regarding the clinical trial application on November 6, 2026.

So what's the key point?

Ensysce Bioscience acquired Sci Biopharma. The company reported $29.7 million in cash assets and received a request from a regulatory agency for more information regarding a clinical trial application.

Source ACCESSWIRE +1 · View original ↗

Related 3-line summaries

Ensys Bioscience Completes Final Enrollment for PF614-MPAR-102 ACCESSWIRE +1 · Aug 31PowerCompute Bitcoin Production Up 35.8% and Turns Profitable InvestorsHub +1 · 14m agoDigi Power X Q3 Revenue Up 85% and AI Revenue Up Over 400% ACCESSWIRE +2 · 14m ago
Today's 5 AI picks, all free
Nothing hidden: past picks and how they did against the S&P 500.
See today's picks →
← Back to news